• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-7a 通过靶向 NIT-1 细胞中的 Raf1 和 Mapkap1 抑制 Isl1 表达来调节胰岛素分泌。

MicroRNA-7a inhibits Isl1 expression to regulate insulin secretion by targeting Raf1 and Mapkap1 in NIT-1 cells.

机构信息

College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu, People's Republic of China.

Institute of Reproduction and Metabolism, Yangzhou University, Yangzhou, 225009, Jiangsu, People's Republic of China.

出版信息

In Vitro Cell Dev Biol Anim. 2021 Sep;57(8):817-824. doi: 10.1007/s11626-021-00611-4. Epub 2021 Oct 28.

DOI:10.1007/s11626-021-00611-4
PMID:34713362
Abstract

Both microRNA-7a (miR-7a) and LIM-homeodomain transcription factor ISL1 are important factors regulating insulin transcription and secretion, but the functional relationship and the interacting mechanisms between miR-7a and ISL1 in pancreatic islet β-cells remain unknown. The aims of this study were thus to identify the potential interactions and signaling communication between miR-7a and ISL1 in regulating insulin transcription and secretion in the cultured NIT-1 cells. The results show that miR-7a inhibitor upregulates Isl-1 and insulin gene expressions, and the insulin secretion. Whereas miR-7a mimics inhibit ISL1 and insulin gene expressions, and decreases the insulin secretion. Furthermore, we identified the target gene of miR-7a using dual-luciferase reporter assay, and the results demonstrate that Raf1 and Mapkap1 is a direct target gene of miR-7a, modeling RAF1/MEK/ERK1/2 and mTORC2/AKT signaling pathway to regulate Isl1 expression, and thus influencing insulin expression and secretion. Our results indicate that therapeutic inhibition of miR-7a function could be of relevance for preserving the function of pancreatic β-cells during the course of diabetes development, implicating miR-7, ISL1, and/or the connecting molecules may act as novel targets for pharmacological or gene therapy in diabetes and related metabolic disease, although much detailed studies are required in the further study.

摘要

miR-7a 和 LIM 同源结构域转录因子 ISL1 都是调节胰岛素转录和分泌的重要因素,但 miR-7a 和 ISL1 在胰岛β细胞中的功能关系和相互作用机制尚不清楚。因此,本研究旨在鉴定 miR-7a 和 ISL1 在调节培养的 NIT-1 细胞中胰岛素转录和分泌中的潜在相互作用和信号通讯。结果表明,miR-7a 抑制剂上调 Isl-1 和胰岛素基因的表达,并增加胰岛素的分泌。而 miR-7a 模拟物则抑制 ISL1 和胰岛素基因的表达,并减少胰岛素的分泌。此外,我们通过双荧光素酶报告基因检测鉴定了 miR-7a 的靶基因,结果表明 Raf1 和 Mapkap1 是 miR-7a 的直接靶基因,通过调节 RAF1/MEK/ERK1/2 和 mTORC2/AKT 信号通路来调节 Isl1 表达,从而影响胰岛素的表达和分泌。我们的结果表明,抑制 miR-7a 的功能可能与在糖尿病发展过程中保护胰岛β细胞的功能有关,这暗示着 miR-7、ISL1 及其连接分子可能成为糖尿病及相关代谢性疾病的药理学或基因治疗的新靶点,尽管还需要进一步的详细研究。

相似文献

1
MicroRNA-7a inhibits Isl1 expression to regulate insulin secretion by targeting Raf1 and Mapkap1 in NIT-1 cells.miRNA-7a 通过靶向 NIT-1 细胞中的 Raf1 和 Mapkap1 抑制 Isl1 表达来调节胰岛素分泌。
In Vitro Cell Dev Biol Anim. 2021 Sep;57(8):817-824. doi: 10.1007/s11626-021-00611-4. Epub 2021 Oct 28.
2
Taurine promotes insulin synthesis by enhancing Isl-1 expression through miR-7a/RAF1/ERK1/2 pathway.牛磺酸通过miR-7a/RAF1/ERK1/2途径增强Isl-1表达来促进胰岛素合成。
In Vitro Cell Dev Biol Anim. 2024 Jan;60(1):23-35. doi: 10.1007/s11626-023-00835-6. Epub 2023 Dec 20.
3
Protein Inhibitor of Activated STAT Y (PIASy) Regulates Insulin Secretion by Interacting with LIM Homeodomain Transcription Factor Isl1.激活 STAT Y 的蛋白抑制剂(PIASy)通过与 LIM 同源域转录因子 Isl1 相互作用调节胰岛素分泌。
Sci Rep. 2016 Dec 21;6:39308. doi: 10.1038/srep39308.
4
The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells.LIM 同源结构域蛋白 ISL1 介导 TCF7L2 在胰腺β细胞中的功能。
J Mol Endocrinol. 2018 Jul;61(1):1-12. doi: 10.1530/JME-17-0181. Epub 2018 Apr 20.
5
LIM-homeodomain transcription factor Isl-1 mediates the effect of leptin on insulin secretion in mice.LIM 同源盒转录因子 Isl-1 介导瘦素对小鼠胰岛素分泌的作用。
J Biol Chem. 2013 Apr 26;288(17):12395-405. doi: 10.1074/jbc.M113.450536. Epub 2013 Mar 15.
6
Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.ISL1(E283D)错义突变与 2 型糖尿病的发生有关。
Diabetologia. 2024 Aug;67(8):1698-1713. doi: 10.1007/s00125-024-06186-5. Epub 2024 May 31.
7
Antisense miR-7 impairs insulin expression in developing pancreas and in cultured pancreatic buds.反义 miR-7 可损害发育中胰腺和培养的胰腺芽中的胰岛素表达。
Cell Transplant. 2012;21(8):1761-74. doi: 10.3727/096368911X612521. Epub 2011 Dec 20.
8
The islet-expressed Lhx1 transcription factor interacts with Islet-1 and contributes to glucose homeostasis.胰岛表达的 Lhx1 转录因子与 Islet-1 相互作用,有助于葡萄糖的稳态平衡。
Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E397-E409. doi: 10.1152/ajpendo.00235.2018. Epub 2019 Jan 8.
9
LIM-domain transcription complexes interact with ring-finger ubiquitin ligases and thereby impact islet β-cell function.LIM 结构域转录复合物与环指泛素连接酶相互作用,从而影响胰岛β细胞功能。
J Biol Chem. 2019 Aug 2;294(31):11728-11740. doi: 10.1074/jbc.RA118.006985. Epub 2019 Jun 11.
10
microRNA-9 and -29a regulate the progression of diabetic peripheral neuropathy ISL1-mediated sonic hedgehog signaling pathway.miRNA-9 和 -29a 通过 ISL1 介导的 sonic hedgehog 信号通路调控糖尿病周围神经病变的进展。
Aging (Albany NY). 2020 Jun 16;12(12):11446-11465. doi: 10.18632/aging.103230.

引用本文的文献

1
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.靶向β细胞可塑性:一种有前景的糖尿病治疗方法。
Curr Issues Mol Biol. 2024 Jul 18;46(7):7621-7667. doi: 10.3390/cimb46070453.
2
Taurine promotes insulin synthesis by enhancing Isl-1 expression through miR-7a/RAF1/ERK1/2 pathway.牛磺酸通过miR-7a/RAF1/ERK1/2途径增强Isl-1表达来促进胰岛素合成。
In Vitro Cell Dev Biol Anim. 2024 Jan;60(1):23-35. doi: 10.1007/s11626-023-00835-6. Epub 2023 Dec 20.
3
An Insight into Vital Genes Responsible for β-cell Formation.
β 细胞形成相关关键基因研究进展
Adv Exp Med Biol. 2024;1450:1-27. doi: 10.1007/5584_2023_778.
4
Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β Cells.血管紧张素 II 通过 miR-375 控制 Mapkap1 的表达并影响胰岛 β 细胞的功能。
Endocr Metab Immune Disord Drug Targets. 2023;23(9):1186-1200. doi: 10.2174/1871530323666230206121715.